JACC. Case reports · 2026
Severe Hypertriglyceridemia Managed in a Pregnant Patient Using Nonstatin Therapies.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Roy Rukmini, Altenberg Marie, Faulkner Shakeela, Dickens Laura, Horan Mary, Davidson Michael, Patel Hena
Аннотация
BACKGROUND: Severe hypertriglyceridemia (HTG) in pregnancy is associated with increased maternal-fetal morbidity. Treatment options remain limited because of fetal safety concerns.
CASE SUMMARY: A 34-year-old pregnant patient with type 2 diabetes mellitus and HTG was referred to our cardio-obstetrics multidisciplinary team for management of HTG at 16 weeks of gestation. She was managed with omega-3 acid ethyl esters, insulin, and lifestyle modifications, with improvement in levels noted over 4 months.
DISCUSSION: This case highlights the complexities of managing severe HTG in pregnancy. Although many lipid-lowering agents are avoided during pregnancy, high-risk women with concurrent type 2diabetes mellitus may be treated with insulin and omega-3 fatty ethyl esters.
TAKE-HOME MESSAGES: Severe HTG in pregnancy is associated with increased risk of maternal-fetal morbidity. Management of severe HTG in pregnancy includes preconception risk assessment, multidisciplinary care, intensive lifestyle modification, selective use of nonstatin agents, and monitoring throughout and after pregnancy.
CASE SUMMARY: A 34-year-old pregnant patient with type 2 diabetes mellitus and HTG was referred to our cardio-obstetrics multidisciplinary team for management of HTG at 16 weeks of gestation. She was managed with omega-3 acid ethyl esters, insulin, and lifestyle modifications, with improvement in levels noted over 4 months.
DISCUSSION: This case highlights the complexities of managing severe HTG in pregnancy. Although many lipid-lowering agents are avoided during pregnancy, high-risk women with concurrent type 2diabetes mellitus may be treated with insulin and omega-3 fatty ethyl esters.
TAKE-HOME MESSAGES: Severe HTG in pregnancy is associated with increased risk of maternal-fetal morbidity. Management of severe HTG in pregnancy includes preconception risk assessment, multidisciplinary care, intensive lifestyle modification, selective use of nonstatin agents, and monitoring throughout and after pregnancy.